For much of 2020, people have hunkered down at home and pondered about life post-pandemic. “Vaccine” became a powerful buzzword, one that generated hope amid a difficult time.
Lauded, yet also questioned, for its rapid development, the race to create an effective vaccine became one of the most anticipated breakthroughs in the world. There were many key players, each of which incorporated their own technologies and innovations. At the moment, the Philippines has mainly distributed three kinds of vaccines to its citizens: the Chinese Sinovac vaccine, the British-Swedish AstraZeneca vaccine, and just recently, the American-made Pfizer BioNTech vaccine. As of writing, the country has been prioritising A1 to A3 subgroups, which consist of frontline healthcare workers, senior citizens and persons with comorbidity. A total of 675,000 have been fully vaccinated…